Single-Tablet Emtricitabine-Rilpivirine-Tenofovir as HIV Postexposure Prophylaxis in Men Who Have Sex With Men

Adherence to HIV postexposure prophylaxis

(2014) Nathan Ford et al.   AIDS

Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials

(2014) Jean B. Nachega et al.   CLINICAL INFECTIOUS DISEASES

HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention

(2014) Deborah Donnell et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapy

(2014) Rubeena Ramjan et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Exploring Concentration Response in HIV Pre-Exposure Prophylaxis to Optimize Clinical Care and Trial Design

(2013) Craig W. Hendrix   CELL

Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence

(2013) J McAllister et al.   HIV MEDICINE

Updated US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis

(2013) David T. Kuhar et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials

(2012) Calvin J. Cohen et al.   AIDS

Skeletal Muscle Toxicity Associated With Raltegravir-Based Combination Antiretroviral Therapy in HIV-Infected Adults

(2012) Frederick J. Lee et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (2011)

(2011) P Benn et al.   INTERNATIONAL JOURNAL OF STD & AIDS